Heart failure and CKD raise mortality risk type 2 diabetes patients Medha Baranwal9 March 2023 8:00 PM ISTSingapore: Among patients with new-onset type 2 diabetes mellitus (T2DM), cardiorenal complications are common and are linked with a high risk of...
Canagliflozin use tied to reduced proteinuria in diabetes patients with HF Dr Kartikeya Kohli7 March 2023 9:00 AM ISTJapan: Proteinuria regression with canagliflozin treatment in patients with T2DM (type 2 diabetes mellitus) and chronic heart failure (CHF) is...
Liraglutide reduces ectopic and visceral liver fat in both diabetics and non-diabetics: Study Medha Baranwal6 March 2023 10:30 AM ISTChina: Liraglutide safely and significantly reduces ectopic and visceral liver fact regardless of the absence or presence of type 2 diabetes (T2D), a...
Sotagliflozin effective and safe in reducing HbA1c among diabetes patients with CKD Medha Baranwal18 Feb 2023 10:15 AM ISTUSA: Sotagliflozin 400 but not 200 mg significantly reduced HbA1c compared with placebo after 26 weeks in adults with type 2 diabetes (T2D) and stage...
Exercise-related hypoglycaemia may increase QTc interval in type 1 diabetes patients Dr Kartikeya Kohli24 Jan 2023 11:00 AM ISTDr Per Hagelqvist and team have found in a new study that in people with type 1 diabetes, both hypoglycemia brought on by exercise and hypoglycemia...
Sleep variability linked to blood sugar control in type 2 diabetes patients Dr Kartikeya Kohli24 Dec 2022 7:15 PM ISTChina: A recent study has suggested a link between objectively-determined sleep duration and sleep midpoint and their daily variability with CGM...
Finerenone prevents progression of non-proliferative diabetic retinopathy: Study Medha Baranwal18 Nov 2022 9:15 AM ISTDenmark: A recent study in Diabetes, Obesity and Metabolism has reported the potential benefit of finerenone for delaying the progression of...
Low-dose lobeglitazone effective against type 2 diabetes, study finds Medha Baranwal16 Sept 2022 11:00 AM ISTSouth Korea: The addition of low-dose lobeglitazone to the combination of metformin and DPP4 inhibitor versus standard-dose lobeglitazone led to...
Expanded dulaglutide weekly doses at par with 1.5 mg dose in type 2 diabetes with CVD risk: Study Medha Baranwal14 Sept 2022 10:45 AM ISTUSA: Findings from a post-analysis of the AWARD-11 study have suggested similar favorable effects of dulaglutide 3.0 mg and 4.5 mg on several...
Foot ulceration in diabetes mellitus associated with high mortality, finds Study Dr. Kamal Kant Kohli26 Aug 2022 9:00 PM ISTCHINA: People who have diabetic foot ulcers (DFUs) die at an excessively high rate, with nearly 50% mortality within 5 years states a research study...
High Glycemic variability and fasting blood sugar increases mortality risk in diabetes patients Jacinthlyn Sylvia20 Aug 2022 10:00 AM ISTChina: A new study suggests that it is crucial to achieve normal and stable glucose levels concurrently since the presence of high glycemic...
Dual hormone or single hormone artificial pancreas- which is better in type 1 diabetes? Medha Baranwal19 July 2022 9:15 PM ISTChina: Dual-hormone artificial pancreas (DH) compared with single hormone artificial pancreas (SH) has a comparable effect on time in target in...
